About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-cre)LC1Bjd
transgene insertion LC1, Hermann Bujard
MGI:2448952
Summary 12 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Slc34a3tm1.1Nhch/Slc34a3tm1.1Nhch
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
involves: 129 * C57BL/6 MGI:5609133
cn2
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sor+
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(tetO-cre)LC1Bjd/0
involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * 129X1/SvJ MGI:4418526
cn3
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Camk2a-tTA)1Mmay/?
Tg(tetO-cre)LC1Bjd/?
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 MGI:3708939
cn4
Grin2btm1Mony/Grin2btm1Mony
Tg(Camk2a-Grin2c/itTA)12Rsp/0
Tg(tetO-cre)LC1Bjd/0
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 MGI:5432105
cn5
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 MGI:5474679
cn6
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL MGI:5307910
cn7
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA MGI:3815301
cn8
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(NPHS2-rtTA2*M2)1Jbk/Tg(NPHS2-rtTA2*M2)1Jbk
Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd
involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N MGI:6402037
cn9
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(NPHS2-rtTA2*M2)1Jbk/Tg(NPHS2-rtTA2*M2)1Jbk
Tg(tetO-cre)LC1Bjd/0
involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N MGI:6402038
cn10
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(PODXL-rtTA*M2)#Mjmr/Tg(PODXL-rtTA*M2)#Mjmr
Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd
involves: 129S/Sv * 129S4/SvJaeSor * BALB/c * C57BL/6J MGI:6402035
cn11
Cdc42tm1Brak/Cdc42tm1Brak
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
involves: BALB/c * C57BL/6 * DBA MGI:5807149
cn12
Wt1tm1.1Ceng/Wt1tm1.1Ceng
Tg(tetO-cre)LC1Bjd/0
Tg(NPHS2-rtTA2*M2)1Jbk/0
involves: BALB/c * C57BL/6 * FVB/N MGI:5512664


Genotype
MGI:5609133
cn1
Allelic
Composition
Slc34a3tm1.1Nhch/Slc34a3tm1.1Nhch
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc34a3tm1.1Nhch mutation (1 available); any Slc34a3 mutation (24 available)
Tg(Pax8-rtTA2S*M2)1Koes mutation (3 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• mice treated with 0.5 mg/ml doxycycline for 5 days followed by 0.25 mg/ml doxycycline for 5 days starting at 3 weeks of age do not display abnormalities in calcium or phosphate homeostasis




Genotype
MGI:4418526
cn2
Allelic
Composition
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sor+
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(rtTA)Awu mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Hif1atm3Rsjo mutation (3 available); any Hif1a mutation (50 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• hypoxic primary tubular epithelial cells from doxycycline treated mice fails to migrate unlike similarly treated cells from Hif1atm3Rsjo/Hif1atm3Rsjo Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sor+ mice




Genotype
MGI:3708939
cn3
Allelic
Composition
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Camk2a-tTA)1Mmay/?
Tg(tetO-cre)LC1Bjd/?
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grin1tm1Rsp mutation (1 available); any Grin1 mutation (66 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• complete loss of NMDAR-mediated long term potential at dentate gyrus synapses
• however, long term potentiation at Schaffer collateral-CA1 synapses is similar to wild-type mice despite residual Cre activity in CA1 pyramidal cells

behavior/neurological
• mice exhibit impaired spatial working memory but normal spatial reference memory in a 3 from 6 radial arm maze task




Genotype
MGI:5432105
cn4
Allelic
Composition
Grin2btm1Mony/Grin2btm1Mony
Tg(Camk2a-Grin2c/itTA)12Rsp/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grin2btm1Mony mutation (0 available); any Grin2b mutation (99 available)
Tg(Camk2a-Grin2c/itTA)12Rsp mutation (1 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• mice exhibit normal motor coordination and spatial reference memory acquisition in a Morris Water maze
• mice exhibit impaired spatial reversal learning compared with control mice
• mice exhibit a small impairment in spatial working memory in an enclosed T maze compared with control mice
• less so than Grin2btm1Mony/Grin2btm1Mony Tg(Camk2a-cre)1Gsc mice
• less so than Grin2btm1Mony/Grin2btm1Mony Tg(Camk2a-cre)1Gsc mice
• less so than Grin2btm1Mony/Grin2btm1Mony Tg(Camk2a-cre)1Gsc mice

nervous system
• in response to the Grin2b antagonist ifenprodil, mice fail to exhibit a strong reduction in NMDA excitatory postsynaptic currents and faster decay kinetics compared with control mice
• in response to the Grin2b antagonist ifenprodil, mice fail to exhibit a strong reduction in NMDA excitatory postsynaptic currents and faster decay kinetics compared with control mice




Genotype
MGI:5474679
cn5
Allelic
Composition
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gabrg2tm2Spet mutation (0 available); any Gabrg2 mutation (41 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• induced by pentylenetetrazil in mice treated with doxycycline treatment between conception and P21 or not treated with doxycycline at all
• induced by pentylenetetrazil compared with Gabrg2tm2Spet heterozygotes
• doxycycline treatment between conception and P21 increased the time to first clonic seizure compared with mice not treated with doxycycline
• however, no seizure kindling effect is observed

nervous system
• induced by pentylenetetrazil in mice treated with doxycycline treatment between conception and P21 or not treated with doxycycline at all
• induced by pentylenetetrazil compared with Gabrg2tm2Spet heterozygotes
• doxycycline treatment between conception and P21 increased the time to first clonic seizure compared with mice not treated with doxycycline
• however, no seizure kindling effect is observed




Genotype
MGI:5307910
cn6
Allelic
Composition
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Npy1rtm1.1Ceva mutation (1 available); any Npy1r mutation (25 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
adipose tissue
• Background Sensitivity: in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal white adipose tissue weight
• Background Sensitivity: in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal white adipose tissue weight
• Background Sensitivity: visceral, epididymal and subcutaneous white adipose tissue in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal white adipose tissue weight

homeostasis/metabolism
• Background Sensitivity: in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal leptin levels
• Background Sensitivity: in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal leptin levels

behavior/neurological
• Background Sensitivity: in an elevated plus maze and open field test, doxycycline-treated mice raised by FVB/J dams exhibit increased anxiety-related behaviors compared with similarly fostered control mice
• however, doxycycline-treated mice fostered by C57BL/6J dams exhibit normal anxiety
• doxycycline-treated mice raised by C57BL/6J dams exhibit decreased total distance traveled in an open field compared with control mice and doxycycline-treated mice raised by FVB/J dams

growth/size/body
• after doxycycline treatment at P41 and P48, mice raised by FVB/J dams, and to a lesser extent raised by C57BL/6J dams, exhibit slower body weight gain compared with control mice

integument
• Background Sensitivity: in doxycycline-treated mice raised by FVB/J
• however, doxycycline-treated mice raised by C57BL/6J dams exhibit normal white adipose tissue weight




Genotype
MGI:3815301
cn7
Allelic
Composition
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Pax8-rtTA2S*M2)1Koes mutation (3 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
Tsc1tm1Djk mutation (2 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• following exposure to doxycycline in utero, mice die 3 to 4 weeks after birth with giant polycystic kidneys

renal/urinary system
• following exposure to doxycycline in utero, newborn mice exhibit fulminant cysts and giant polycystic kidneys form by 3 to 4 weeks of age
• following exposure to doxycycline in utero, new born mice exhibit hyperplasia of the proximal and distal tubules and collecting duct epithelium

growth/size/body
• following exposure to doxycycline in utero, newborn mice exhibit fulminant cysts and giant polycystic kidneys form by 3 to 4 weeks of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autosomal recessive polycystic kidney disease DOID:0110861 J:140925




Genotype
MGI:6402037
cn8
Allelic
Composition
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(NPHS2-rtTA2*M2)1Jbk/Tg(NPHS2-rtTA2*M2)1Jbk
Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd
Genetic
Background
involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(NPHS2-rtTA2*M2)1Jbk mutation (1 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• in primary podocyte cell cultures from doxycycline-treated mice

homeostasis/metabolism
• in doxycycline-treated mice
• within the first 3 weeks following treatment with a high dose (50 ug/g) of doxycycline
• however, a lower doxycycline dose (15 ug/g) that produces FSGS does not affect lethality

mortality/aging
• within the first 3 weeks following treatment with a high dose (50 ug/g) of doxycycline
• however, a lower doxycycline dose (15 ug/g) that produces FSGS does not affect lethality

renal/urinary system
• in doxycycline-treated mice
• with vacuolization after 10 days in mice treated with doxycycline
• reduced density in mice treated with doxycycline
• from 3 weeks of age, doxycycline-treated mice exhibit focal segmental glomerulosclerosis (FSGS) with adhesions, segmental accumulation of matrix, capillary hyalinosis, loss of capillaries, and declining glomerular numbers through 13 weeks unlike control mice
• however, mice do not develop FSGS when doxycycline is administered antenatally or at 10 and 11 days after birth or when mice are treated with a low dose of doxycycline (1.5 ug/g)
• in doxycycline-treated mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
focal segmental glomerulosclerosis DOID:1312 OMIM:PS603278
J:285673




Genotype
MGI:6402038
cn9
Allelic
Composition
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(NPHS2-rtTA2*M2)1Jbk/Tg(NPHS2-rtTA2*M2)1Jbk
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(NPHS2-rtTA2*M2)1Jbk mutation (1 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• doxycycline-treated mice do not exhibit focal segmental glomerulosclerosis




Genotype
MGI:6402035
cn10
Allelic
Composition
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor
Tg(PODXL-rtTA*M2)#Mjmr/Tg(PODXL-rtTA*M2)#Mjmr
Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd
Genetic
Background
involves: 129S/Sv * 129S4/SvJaeSor * BALB/c * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(PODXL-rtTA*M2)#Mjmr mutation (0 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• doxycycline-treated mice do not exhibit focal segmental glomerulosclerosis




Genotype
MGI:5807149
cn11
Allelic
Composition
Cdc42tm1Brak/Cdc42tm1Brak
Tg(Pax8-rtTA2S*M2)1Koes/0
Tg(tetO-cre)LC1Bjd/0
Genetic
Background
involves: BALB/c * C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdc42tm1Brak mutation (0 available); any Cdc42 mutation (45 available)
Tg(Pax8-rtTA2S*M2)1Koes mutation (3 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• following ischemia/reperfusion injury, doxycycline-treated mice exhibit a misorganized, multi-layered, hyperproliferative epithelium and impaired recovery of renal function

renal/urinary system
• following ischemia/reperfusion injury, doxycycline-treated mice exhibit a misorganized, multi-layered, hyperproliferative epithelium and impaired recovery of renal function
• following ischemia/reperfusion injury, doxycycline-treated mice exhibit a misorganized, multi-layered, hyperproliferative epithelium and impaired recovery of renal function
• dividing cells of doxycycline-treated mice during kidney repair show a high shift toward mitotic spindle angles perpendicular to the epithelial plane
• however, doxycline-treated mice exhibit normal kidney histology and function under basal conditions




Genotype
MGI:5512664
cn12
Allelic
Composition
Wt1tm1.1Ceng/Wt1tm1.1Ceng
Tg(tetO-cre)LC1Bjd/0
Tg(NPHS2-rtTA2*M2)1Jbk/0
Genetic
Background
involves: BALB/c * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(NPHS2-rtTA2*M2)1Jbk mutation (1 available)
Tg(tetO-cre)LC1Bjd mutation (2 available)
Wt1tm1.1Ceng mutation (0 available); any Wt1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• progressive in doxycycline-treated mice
• focal segmental glomerulosclerosis in doxycycline-treated mice

homeostasis/metabolism
• progressive in doxycycline-treated mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory